CASPAR (Alliance A031902) - A Randomized, Phase III Trial of Enzalutamide with/without Rucaparib as a Novel Therapy in First-Line Metastatic Castration-Resistant Prostate Cancer (mCRPC)
- Citation:
- J Clin Oncol vol 40 (16_suppl) TPS5107
- Meeting Instance:
- ASCO 2022
- Year:
- 2022
- Type:
- Abstract
- Sub type:
- Poster General
- Funding:
- NCTN
- Endpoint:
- No-Endpoint
- Analysis:
- Trial-Description-Only
- Data Sharing:
- No-Data-Sharing
- Status:
- Presented/Published
- Citation Status:
- epub
- Note:
- Methodological:
- No
- Biospecimen:
- No
- SDC:
- Yes
- Parents:
- None
- Children:
- None
- Pharmas:
- Grants:
- U10CA180821, U10CA180882
- Corr. Author:
- Authors:
- Arpit Rao Charles J Ryan David Vanderweele Glenn Heller Lionel D. Lewis Colleen Watt Ronald C Chen Robert Grubb Olwen Hahn Himisha Beltran Michael J Morris
- Networks:
- KANSAS, LAPS-IL036, LAPS-IL057, LAPS-MA036, LAPS-NH012, LAPS-NY016, MN022, MUSC, TX041
- Study
- Alliance-A031902
- Multiple Studies, or Legacy Studies in Alliance Study:
- Phases:
- 3
- Keywords: